Please login to the form below

Not currently logged in


This page shows the latest Lenvima news and features for those working in and with pharma, biotech and healthcare.

Eisai’s Lenvima wins European liver cancer indication

Eisai’s Lenvima wins European liver cancer indication

Eisai’ s Lenvima wins European liver cancer indication. EC green-lights the RTK inhibitor as a first-line treatment. ... Additionally, Lenvima also demonstrated statistically significant superiority and clinically meaningful improvements compared to

Latest news

More from news
Approximately 9 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...